Irina Matytsina, MD, MSc Pharm Med

International Medical Director
Novo Nordisk A/S
Bagsvaerd, Hovedstaden, Denmark

Irina Matytsina, MD, MSc Pharm Med, is a medical specialist at Novo Nordisk A/S. Since joining the company in 2010, Irina has been working with clinical development of therapeutics for treatment of Hemophilia. Prior to her role at Novo Nordisk, she was a medical specialist in other Danish pharmaceutical and biotech companies.

Presentation(s):

• PB0156 - Higher Thrombin Generation Is Predicted When Switching Directly From Emicizumab to MIM8 in Patients With Hemophilia A

  Sunday, June 25, 2023
  18:30 – 19:30 ET

• PB1315 - Weight-band dosing with Mim8: using modelling to support a streamlined approach to haemophilia A treatment

  Tuesday, June 27, 2023
  18:30 – 19:30 ET